Sign in
4

Changes in Ownership

MAIA Biotechnology, Inc. Filed Acc 0001127602-25-018655

Options or other derivatives

  • Director acquired 25,232 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Louie Ngar Yee Director 2025-06-30 Grant or award · Stock Options +25,232 25,232 D: show line 1 in the form
Loading xslF345X05/form4.xml…